EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel antiviral formulation containing caprylic acid inhibits SARS-CoV-2 infection of a human bronchial epithelial cell model

Kevin Purves, Ruth Haverty, Tiina O'Neill, David Folan, Sophie O'Reilly, Alan W Baird, Dimitri Scholz, Patrick W Mallon, Virginie Gautier, Michael Folan, Nicola F Fletcher

Journal of General Virology · 2023

DOI: 10.1099/jgv.0.001821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of General Virology, 2023. Verfasst von Kevin Purves und 10 weiteren Autor:innen. Beteiligte Einrichtung: Veterinary Sciences Centre, University College Dublin, Belfield, Dublin, Ireland. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UCD Foundation, Irish Research Council for Science, Engineering and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel proprietary formulation, ViruSAL, has previously been demonstrated to inhibit diverse enveloped viral infections in vitro and in vivo . We evaluated the ability of ViruSAL to inhibit SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) infectivity , using physiologically relevant models of the human bronchial epithelium, to model early infection of the upper respiratory tract. ViruSAL potently inhibited SARS-CoV-2 infection of human bronchial epithelial cells cultured as an air–liquid interface (ALI) model, in a concentration- and time-dependent manner. Viral infection was completely inhibited when ViruSAL was added to bronchial airway models prior to infection. Importantly, ViruSAL also inhibited viral infection when added to ALI models post-infection. No evidence of cellular toxicity was detected in ViruSAL-treated cells at concentrations that completely abrogated viral infectivity. Moreover, intranasal instillation of ViruSAL to a rat model did not result in any toxicity or pathological changes. Together these findings highlight the potential for ViruSAL as a novel and potent antiviral for use within clinical and prophylactic settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsCOVID-19HumansRatsAnimalsSARS-CoV-2Epithelial CellsBronchiCaprylates

Stichwörter der Autor:innen

antiviralcaprylatecaprylic acidcoronavirusenveloped virusviral envelope

Substanzen

Antiviral Agentsoctanoic acidCaprylates

Autor:innen und Institutionen

  • Veterinary Sciences Centre, University College Dublin, Belfield, Dublin, Ireland.
  • Conway Institute of Biomedical and Biomolecular Research, University College Dublin, Belfield, Dublin, Ireland.
  • Westgate Biomedical Ltd, Lough Eske, Donegal Town, Co. Donegal, Ireland.
  • Centre for Experimental Pathogen Host Research, University College Dublin, Belfield, Dublin, Ireland.
  • Department of Infectious Diseases, St Vincent's University Hospital, Dublin, Ireland.

Förderung

  • UCD Foundation
  • Irish Research Council for Science, Engineering and Technology

Zitieren

APA

Purves, K., Haverty, R., O'Neill, T., Folan, D., O'Reilly, S., Baird, A. W., Scholz, D., Mallon, P. W., Gautier, V., Folan, M., & Fletcher, N. F. (2023). A novel antiviral formulation containing caprylic acid inhibits SARS-CoV-2 infection of a human bronchial epithelial cell model. Journal of General Virology. https://doi.org/10.1099/jgv.0.001821

Vancouver

Purves K, Haverty R, O'Neill T, Folan D, O'Reilly S, Baird AW, et al. A novel antiviral formulation containing caprylic acid inhibits SARS-CoV-2 infection of a human bronchial epithelial cell model. Journal of General Virology. 2023. doi:10.1099/jgv.0.001821

BibTeX
@article{Purves2023,
  author = {Purves, Kevin and Haverty, Ruth and O'Neill, Tiina and Folan, David and O'Reilly, Sophie and Baird, Alan W and Scholz, Dimitri and Mallon, Patrick W and Gautier, Virginie and Folan, Michael and Fletcher, Nicola F},
  title = {A novel antiviral formulation containing caprylic acid inhibits SARS-CoV-2 infection of a human bronchial epithelial cell model},
  journal = {Journal of General Virology},
  year = {2023},
  doi = {10.1099/jgv.0.001821}
}
Kostenlos starten →